SEC FORM 4
—
HERON THERAPEUTICS, INC. /DE/ (HRTX)
Acquisition (code M) of 13,797 shares; price not stated (see filing).
Reporting Person Collard Craig A · Officer Title Chief Executive Officer · Transaction Code M
Traded Oct 19, 2026 · Disclosed Oct 21, 2026
Source: SEC Form 4 · 0001193125-26-427524 · filed 2026-10-21 · View filing →